{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["17(17)"],"submitter":["Ghahremanifard P"],"pubmed_abstract":["<h4>Background</h4>The SUMO E3 ligase PIAS1 (Protein Inhibitor of Activated STAT1) regulates pathways such as TGFβ signaling and has been implicated in multiple cancers. However, its role in the tumor microenvironment (TME), particularly in non-malignant stromal and immune cells, remains poorly understood. This study aimed to characterize the expression and functional relevance of PIAS1 within the TME of oral squamous cell carcinoma (OSCC).<h4>Methods</h4>PIAS1 protein expression was assessed via immunohistochemistry (IHC) on OSCC tissue microarrays. Single-cell RNA-sequencing (scRNA-seq) datasets from OSCC tumors and normal tissues were analyzed to map cell-type-specific PIAS1 expression. Downstream effects were evaluated using differential gene expression, Ingenuity Pathway Analysis (IPA"],"journal":["Cancers"],"pagination":["2905"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12427710"],"repository":["biostudies-literature"],"pubmed_title":["PIAS1 Shapes a Tumor-Suppressive Microenvironment by Suppressing Immune Evasion in Oral Squamous Cell Carcinoma."],"pmcid":["PMC12427710"],"pubmed_authors":["Nakoneshny SC","Dort JC","Chan AMY","Hart RD","Ghahremanifard P","An J","Chanda A","Hyrcza MD","Bonni S","Chandarana SP","Matthews TW","Bose P"],"additional_accession":[]},"is_claimable":false,"name":"PIAS1 Shapes a Tumor-Suppressive Microenvironment by Suppressing Immune Evasion in Oral Squamous Cell Carcinoma.","description":"<h4>Background</h4>The SUMO E3 ligase PIAS1 (Protein Inhibitor of Activated STAT1) regulates pathways such as TGFβ signaling and has been implicated in multiple cancers. However, its role in the tumor microenvironment (TME), particularly in non-malignant stromal and immune cells, remains poorly understood. This study aimed to characterize the expression and functional relevance of PIAS1 within the TME of oral squamous cell carcinoma (OSCC).<h4>Methods</h4>PIAS1 protein expression was assessed via immunohistochemistry (IHC) on OSCC tissue microarrays. Single-cell RNA-sequencing (scRNA-seq) datasets from OSCC tumors and normal tissues were analyzed to map cell-type-specific PIAS1 expression. Downstream effects were evaluated using differential gene expression, Ingenuity Pathway Analysis (IPA","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-04-23T03:25:47.802Z","creation":"2026-04-23T03:12:32.886Z"},"accession":"S-EPMC12427710","cross_references":{"pubmed":["40941002"],"doi":["10.3390/cancers17172905"]}}